The difficult translational pathway from animal models to patients

Area of Science:

• Hematology
• Molecular Biology
• Gene Therapy

Background:

• Hematopoietic stem and progenitor cells (HSPCs) are crucial for blood cell formation and are a target for gene therapy.
• Lentiviral vectors and CRISPR-Cas9 gene editing are common tools for modifying HSPCs.

Purpose of the Study:

• To compare the efficacy of lentiviral vector transduction versus CRISPR-Cas9/homology-directed repair (HDR) editing in HSPCs.
• To assess the impact of these gene modification methods on HSPC engraftment and clonal dynamics in vivo.

Main Methods:

• Analysis of HSPC engraftment and clonal dynamics after lentiviral vector transduction.
• Analysis of HSPC engraftment and clonal dynamics after CRISPR-Cas9/HDR editing.

Main Results:

• Homology-directed repair editing demonstrated lower efficiency in vivo compared to lentiviral vector-mediated gene addition.
• CRISPR-Cas9/HDR editing may negatively affect the engraftment and differentiation capabilities of HSPCs.

Conclusions:

• CRISPR-Cas9/HDR editing is currently less efficient for in vivo HSPC modification than lentiviral vectors.
• Further research is needed to optimize HDR editing for clinical applications in gene therapy.